PCR

The EARLY TAVR trial is one of the most-talked about trials of this year's TCT. In this review, Luigi Biasco provides his take on the results of this trial, presented by Philippe Généreux at #TCT2024 in Washington 🔗 https://lnkd.in/drtjUcM7 #TAVI #TAVR #clinicaltrials

#TCT2024 🇺🇸 Late-breaking Trials Cardiovascular Research Foundation Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis (#TAVR UNLOAD) My interview 🎤Nicolas Van Mieghem who presented the results 📊 of the trial in Washington. 📺PCR https://lnkd.in/dviBe95V #TAVI #LBCT Azeem Latib thomas modine Hélène Eltchaninoff Martine Gilard alaide chieffo Khaled Shaibi wail alkashkari وائل القشقري

📖Early reperfusion therapy is vital for patients with ST-segment elevation myocardial infarction, with primary PCI being the preferred method. Explore or revisit this chapter of the PCR #EAPCI textbook on #STEMI interventions by Carlo Di Mario, Giuseppe De Luca, Artur Dziewierz, Tomasz Rakowski and with the personal perspective of Dariusz Dudek! Free reading available until 2 November➡️ https://bit.ly/3Ix6IKd

How do you navigate the complexities of performing #TAVI on an #aorta previously treated for coarctation #surgery, while ensuring patient safety? 🔗 https://lnkd.in/d3aWM5tb Giuseppe Bruschi, Igor Belluschi, Bruno Merlanti, Benedetta De Chiara, Marco Solcia, and Claudio Russo share their experience in this image and case published in collaboration with EuroIntervention #TAVR #CardioEd #cardiology

When should you choose DCB for de novo lesions? Join coordinator Andreas Baumbach and speakers Javier Escaned and Bruno Scheller to explore whether drug-coated balloons (DCB) should be the first choice, in part one of a three-part series. This free #PCRwebinar will leave you with practical insights, and impact your treatment decisions. 💻 Drug-coated balloons as a first choice for patients with de novo lesions: pros and cons 🗓️ Friday 8 November 2024, 4:00pm (UTC+1) 🔗 Register now for free: https://lnkd.in/eSFxj-rP P.S. Continue your learning experience! Part two coming on 29 November, where you'll cover DCB’s role in managing in-stent restenosis.

#EAPCI/PCR Journal Club: Immediate versus staged complete revascularisation in patients presenting with #STEMI and MVD. 🔗 https://lnkd.in/eHn9ctii The current subanalysis 📊 of the BioVasc trial offers valuable insights into the long-term effects of ICR versus SCR strategies: findings support current guidelines on the necessity of revascularizing non-culprit lesions. Read this review by Ali Nazmi Çalık and Murat Gökalp of an article selected in EuroIntervention #interventionalcardiology #journalclub

Where it all began... For most, #PCRLV began in 2010, but for Simon Redwood, it started in 2009, when it was still called London Valve Live. With only 200 participants and live cases from Saint Thomas’ Hospital, it was a small but impactful event. Today, it has evolved into the world’s largest multinational conference in interventional cardiology, thanks to the innovative spirit and collaboration of everyone involved. Be part of it! Join your peers on 24-26 November in London: https://lnkd.in/dv_pbe7 #Interventionalcardiology #cardioed francesco maisano Nicolo Piazza Bernard Prendergast Didier Tchetche Nina C. Wunderlich, MD, FESC, FACC Marco Barbanti Andreas Baumbach Sabine Bleiziffer Patrick Calvert Chris Cook Sam Dawkins Ole De Backer Chiara De Biase erwan donal Rodrigo Estévez Loureiro, MD, PhD, FESC Jörg Hausleiter Farrel Hellig Nicole KARAM Philipp Lurz, MD, PhD Antoinette Neylon Tiffany Patterson Tanja Rudolph Nicolas Van Mieghem Hendrik Feller

How will TRISCEND II findings influence your clinical decisions for tricuspid valve disease? Join chair Volker Rudolph and speakers Julien Dreyfus, Alison Duncan and Philipp Lurz, MD, PhD to explore how TTVR can improve patient outcomes. This free #PCRwebinar will keep you up to date in the latest advancements in interventional cardiology. You'll find out more about the benefits and limitations of TTVR, how to identify ideal patients, and learn when to exercise caution! 🗓️ Tuesday 12 November 2024, 5:00pm (UTC+1) 🔗 Register for free: https://lnkd.in/emXKWtUY

The 3rd edition of PCR Imaging Valves Madrid promises a dynamic 2-day workshop with 2 crossover programmes adapted to your daily practice environment:  👨🏽⚕️ for the heart valve clinic and outpatients  🏥 for the cathlab team.  State-of-the-art tutorials and hands-on training will cover the aortic, mitral, tricuspid and multivalvular disease, around imaging techniques such as echo, CT-scan, MRI and fusion. 🎤 Learn more from Pepe Zamorano and dive into the #PCRimaging programme: https://lnkd.in/diYZBnMF #Interventionalcardiology #imagingfirst #echofirst   Nina Ajmone Marsan Victoria Delgado Madalina Garbi Rebecca Hahn Denisa Muraru

TAVI in bicuspid aortic stenosis: when and how? Join renowned experts Dejan Milasinovic and Ole De Backer for an engaging Heart to Heart Conversation on "TAVI in bicuspid aortic stenosis: when and how?". Don’t miss this unique opportunity to gain valuable insights into cutting-edge cardiology by watching this live conversation.